|
|
|
|
|
|
|
EMD Chemicals Inc. EMD Chemicals Inc.,specialty chemicals, pharmaceutical, biotech, cosmetic, automotive, plastics, industrial applications,bioscience,pigments, liquid crystal,
|
Affygility Solutions Providing potent compound safety, control banding, compound categorization, occupational toxicology, chemical toxicology, industrial hygiene, OSHA compliance support services to the biotechnology, pharmaceutical, medical...
|
Cilag AG, Centocor Cilag AG is an international operating company integrated in the Pharmaceuticals Group of Johnson & Johnson that provides its customers with highest quality active pharmaceutical ingredients and pharmaceutical products...
|
Inalco Pharmaceuticals Inalco is a primary manufacturer of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Intermediates, high purity enzyme substrates and other fine biochemicals.
|
Polymed For the past decade our API division has been a leader in the supply of pharmaceutical grade yet low cost specialty active ingredients and intermediates, for the global market. Our product portfolio has since expanded...
|
Ferro Ferro is the leading global supplier of technology-based performance materials for manufacturers. Ferro materials enhance the performance of products in a variety of end market applications, including electronics, solar...
|
Johnson Matthey Intertwining strength, leadership and technical capabilities, the Johnson Matthey Pharmaceutical Materials and Services business units, as part of Johnson Matthey’s worldwide Fine Chemical & Catalysis Division, become one...
|
|
|
|
|
|
More
Pharmaceutical Active Ingredients
Research Library
|
|
EMD Chemicals Inc.
|
Cyclooxygenases (COXs), also known as prostaglandin H synthases, are fatty acid oxygenases that contain about 600 amino acid residues and act on arachidonic acid to generate prostaglandins (PG). All vertebrates contain two COX genes: one encoding the constitutive COX-1 and another inducible COX-2. COX-1 and COX-2 share approximately 60-65% amino acid identity. These COX isoforms are bifunctional ...
|
|
|
SafeBridge Consultants, Inc.
|
Potent and highly potent active pharmaceutical ingredients have the potential to cause serious health effects in workers at very low airborne concentrations. The use of containment equipment as part of a systematic approach to potent compound safety is advised to control worker exposure. However the containment performance of equipment can not be assumed, evaluation of containment performance, ...
|
|
|
SafeBridge Consultants, Inc.
|
Chemical categorization (or banding) of inherent toxicity and potency linked with defined safe work environments including exposure controls has become an integral component of assuring the health and safety of research workers and manufacturing personnel in the pharmaceutical industry but is not a substitute for quantitative risk assessment in the workplace.
|
|
|
EMD Chemicals Inc.
|
In unstressed cells, p53 is latent and is maintained at low levels by targeted degradation mediated by MDM2. Through its binding to p53, MDM2 can shuttle p53 out of the nucleus into the cytoplasm for degradation. When normal mammalian cells are subjected to stress signals, such as hypoxia, radiation, and chemotherapeutic drugs, p53 is phosphorylated at multiple sites, including those involved in ...
|
|
|
EMD Chemicals Inc.
|
Transforming growth factor- (TGF-), a member of the TGF superfamily of proteins that includes activins, inhibins, and bone morphogenetic proteins (BMPs), regulates a wide array of cellular processes including cell differentiation, cellular senescence, immune response, wound healing, and apoptosis. TGF- signaling promotes growth and development during early embryogenesis. However, in mature ...
|
|
|
|
|
|
|
Pharmaceutical Active Ingredients
Video
|
|
|
Filamatic
|
V Automatic Vertical Series
The compact Series V machine uses interchangeable filling units to dispense a wide variety of free-flowing to viscous ...
|
|
|
|
StudyManager, Inc
|
StudyManager Sponsor Edition (SE) dramatically improves study performance with real-time interaction and clinical data collection for pharmaceutical and ...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
